Clinical-stage pharma stock Theralase Technologies (TSXV:TLT) announced a significant breakthrough in the treatment of Herpes ...

Topical medication. Treatment for HSV-1 outbreaks varies according to the severity of the lesions, as well as the degree of need for comfort and support for the individual affected (see Table 1).

To date, there are no approved commercially available vaccines, and anti-HSV-1 drugs such as specific or non-specific nucleotide (nucleoside) analogs and helicase-primase inhibitors have become the ...

University of Manitoba independent research verifies that RuvidarTM is more effective than acyclovir in the inactivation of Herpes Simplex Viruses post infection. TORONTO, ON / ACCESS Newswire / ...

There is currently no cure for either HSV-1 or HSV-2. Therefore, it is important to reduce the risk of transmission. Several precautions can help prevent the spread of HSV, including: Looking for ...

Treatment can even be started before this if you recognize the prodromal signs of ... Less commonly, anal herpes can be caused by herpes simplex virus type 1 (HSV-1), the type commonly associated with ...

According to recent estimates from the World Health Organization, more than one in five people aged 15–49 live with genital herpes.

Treatment can even be started before this if ... Less commonly, anal herpes can be caused by herpes simplex virus type 1 (HSV-1), the type commonly associated with cold sores.

Whereas HSV-1 latency is found only in cranial nerve ganglia, HSV-2 becomes latent in lumbrosacral ganglia. The treatment for HSV-2 encephalitis is the same as for HSV-1 (see above). HSV ...

HSV-1 and HSV-2 shedding were detected qualitatively by PCR using the LightCycler HSV ... In none of these cases were symptoms significant enough for the participant to seek additional investigation ...

HSV-1 can spread through close contact ... Recognizing these origins is key to selecting the right treatment. This prodromal phase, which occurs before any visible symptoms, is unique to cold ...